250 words 28 Background: Bone wax is used in surgery as a hemostatic device for bone. Despite its good 29 functional capacity as a bone hemostat, Bone wax materials often have very poor long-term 30 interactions with bone. This study describes a novel composite of hydroxyapatite (HA) and 31 biodegradable poly-lactic acid (PLA) with wax-like handling properties (OsteoStat). The goal 32 was to compare qualitative and quantitative measures between OsteoStat versus Bone wax. 33 Methods: The porcine critical size defect model was chosen in this study. OsteoStat and Bone 34 wax were introduced into separate critical size defects located in the femur and humerus of a 35 single porcine specimen. After a duration of 6 weeks, the defect sites were harvested for clinical, 36 histological, and histomorphometric analysis.
6 at the right humerus and contralateral left femur. Tissue dissection was performed, exposing the 112 underlying periosteum at these respective sites. Four test sites were chosen for the bone defect, 2 113 holes located in the right diaphyseal humerus and 2 holes located in the left diaphyseal femur. 114 All test sites were drilled to have standardized intraosseous defects with a circumference of 3cm 115 and equal depth. Care was taken to drill the cortical bone down to a similar depth in all the drill 116 sites. One defect on each bone (humerus or femur) was filled with OsteoStat (Hemostasis LLC, 117 MN, USA) and the other defect was filled with Bone wax W31G (Ethicon, NJ, USA). The 118 surgical sites were closed in multiple layers. 119 The animal was given a healing period of 6 weeks before it was sacrificed. During the 120 healing period, the animal displayed no signs of local infection and surgical site incisions were 121 well healed. The animal was fully ambulant during the entire period and was effectively load 122 bearing on all four limbs. After the healing period, the animal was sacrificed with an overdose of 123 pentobarbital sodium. The right humerus and left femur diaphysis were cut to harvest the test 124 sites as discrete blocks. On harvesting of the test sites, no signs of gross inflammation or necrosis 125 were observed in any of the sites.
126

Histology Preparation
127
The harvested blocks of tissue containing the test sites were fixed with a 10% neutral 128 buffered solution of formalin for a period of 7 days. The blocks were then decalcified by a 129 solution of mixed acid decalcification agent for 6 weeks. Next, the sections were dehydrated with 130 ethanol gradient and prepared with paraffin. Hematoxylin and Eosin (H&E) stain was applied to 131 the sections for histological observation at x40, x100, and x 400 magnification. Two sections 132 were prepared from each of the 4 drilled sites, for a total of 8 sections for 133 7 histological/histomorphometric analysis (4 sections for the OsteoStat defect and 4 sections for 134 the Bone wax defect).
135
Histomorphometric Evaluation
136
Two sections per drilled site were used for histomorphometric analysis, for a total of 4 137 sections per test material. Analysis was done at the x40 power magnification level, as this would 138 give a balance between tissue resolution and reduction in section variability, which would be 139 greatly biased at higher power magnification. Histomorphometric data was obtained by addition to the soft tissue stroma. Furthermore, new vessel formation was observed in some of 157 the sections (Fig. 1) . In the Bone wax sites, fibrous soft tissue stroma was the predominating 158 component. Some new bone can also be seen, and there is also the presence of undegraded test 159 material. The amount of new bone appears visually less than in the OsteoStat sites (Fig. 2) . tissue and some new bone is also present, but as immature bony trabeculae (Fig. 4) . trabeculae. Osteocytes are also present in the bony matrix. No osteoclasts are seen (Fig. 5) . 185 Similarly, the Bone wax site (Fig. 6) shows osteoblast activity lining the bony trabeculae, with 186 no osteoclasts. The variation in sections at the x400 magnification is inherently greater. composite were 12.31%, 49.64%, and 38.05% respectively. In the Bone wax group, the mean 202 area fractions of test material, soft tissue and bone were 16.08%, 72.04%, 11.88% and 203 respectively ( Table 1) . The difference in bone area fraction between the OsteoStat group 204 (38.05%) and the Bone wax group (11.88%) was significant (p = 0.028) ( Table 2 ). The soft 205 tissue area fraction in the OsteoStat group (49.64%) was also less than the Bone wax group 206 10 (72.04%); however, this result was not statistically significant (p = 0.089). Similarly, the amount 207 of test material remaining in the OsteoStat group (12.31%) was less than the Bone wax group 208 (16.08%) and was also not statistically significant (p = 0.421). for these parameters did not meet the threshold for statistical significance. This might be because The funder provided support in the form of salaries for authors JS JB KR, but did not have
